Invest in essential sectors like consumer staples and energy to beat inflation. See why these stocks offer reliable dividends ...

BioXcel Therapeutics, Inc. (NASDAQ:BTAI), a pharmaceutical company with a market capitalization of $14.83 million, announced today the implementation of a 1-for-16 reverse stock split of its common ...

Eton Pharmaceuticals, Inc ("Eton" or the "Company") (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

Tonix Pharmaceuticals (NASDAQ: TNXP) will implement a 1-for-100 reverse stock split, effective at <a target=_blank href= ...

Financial giants have made a conspicuous bearish move on Vertex Pharmaceuticals. Our analysis of options history for Vertex ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline ...

CHATHAM, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical ...

The healthcare industry is set for growth due to advancements in targeted treatments and personalized care and the rapid ...

GlycoMimetics Inc. (NASDAQ:GLYC), a pharmaceutical company with a market capitalization of $17.28 million, has announced the impending departure of two top executives, as detailed in a recent 8-K ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...